You are here: Industry Insights > acquisition

News List

Strand Life Sciences in agreement with Quest Diagnostics expressbpd
October 09, 2018
The former will acquire the India medical diagnostics business of Quest Diagnostics
BioIVT Acquires CTLS contractpharma
October 09, 2018
Enables BioIVT to ship fresh blood and blood-derived products to researchers anywhere in Europe within 24 hours
Sun Pharma to buy minority stake in Israeli firm biospectrumasia
September 29, 2018
Sun Pharma will make the acquisition through a wholly owned subsidiary.
Allergan to Acquire Bonti for $195M contractpharma
September 17, 2018
Adds new neurotoxin programs to medical aesthetics pipeline
Boehringer Ingelheim exercises option to buy ViraTherapeutics, boosting viral-based approach to treating cancer biospectrumasia
September 14, 2018
Boehringer Ingelheim announced Thursday that it has acquired all shares of ViraTherapeutics for a total of 210 million euros ($244 million), with the price based on an option and share purchase agreement signed between the companies in 2016.
Takeda set to move from Deerfield Illinois, 1000 jobs affected pharmafile
September 13, 2018
Japanese multinational Takeda is set to shut down its US headquarters in Deerfield, Illinois following the final stages of its Shire Plc acquisition.
Sun Pharma arm to acquire shares of Israeli firm Tarsius Pharma for $3 mn financialexpress
September 12, 2018
Indicative time period for completion of the acquisition is before September 15, 2018, Sun Pharma said
Otsuka Pharmaceutical Completes Acquisition of Visterra americanpharmaceuticalreview
September 05, 2018
Visterra announces that Otsuka Pharmaceutical has completed the acquisition of Visterra for approximately $430 million in an all-cash transaction. The acquisition was completed on August 31, 2018.
SOTIO acquires Cytune Pharma biospectrumasia
September 03, 2018
All Cytune projects will be developed as part of SOTIO’s pipeline.
China Biologic announces updates on unsolicited acquisition proposals biospectrumasia
August 28, 2018
After careful review of the Consortium's proposal, the Board has unanimously determined that it is not in the best interests of the Company and its shareholders

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page